Celebrating Our Shared Success: An Annual General Meeting Report

Foundation of the Regional heat Hospital Reports $956,598 Investment in patient care

Bathurst,NB – The Foundation of the Regional Heat Hospital recently concluded its 33rd Annual General Meeting,presenting a report detailing activities for the 2022-2023 financial year. The full annual report is available for review at https://www.fondationchaleur.ca/impact/rapport-annuel/.

the report highlights the notable impact of community support in bolstering primary healthcare services within the region. This support directly funded the acquisition of advanced medical equipment and provided crucial assistance to healthcare professionals. A total investment of $956,598 was allocated across key areas: $807,015 to patient care sectors, $144,405 to diagnostic sectors, and $5,178 towards staff improvements and other vital resources.

During the meeting, the President extended gratitude to the dedicated volunteers and donors whose commitment fuels the Foundation’s success. This year’s achievements build upon a strong track record, with over $20 million invested in improvements to the Regional Heat hospital since 1990.

“Your contributions have demonstrably improved the quality of care we can provide to our patients, ensuring access to state-of-the-art medical equipment,” stated Jean-Guy Robichaud, Chairman of the Board of Directors.”We are deeply grateful for the unwavering solidarity of the community surrounding the foundation. Together, we can continue to enhance the lives of both patients and our dedicated hospital staff. Thank you for your continued commitment!”

The Foundation’s Board of Directors includes: Jean-Guy Robichaud (President), Jennifer Cleversey-Moffitt (Vice-President), Colin Brewster (Treasurer), Jessica Poirier (Secretary), Dr. Natalie Banville (Director), Dianne Hachey, Clifford Robichaud, Christina Mallet Aubut, Monique Boudreau, Alice Hébert, Dr. John Leblanc, Danielle Goyette, and joceline Maillet-Boudreau.

The Foundation of the Regional Heat Hospital plays a critical role in collaborating closely with the hospital to identify and address evolving healthcare needs and to foster community engagement.

Disclaimer: This article reports on the activities of the Foundation of the Regional Heat Hospital and is based on data provided in their official annual report and press release. While we strive for accuracy,this is not a substitute for professional medical or financial advice. For specific healthcare concerns, please consult with a qualified healthcare provider.For financial planning, consult with a financial advisor.

Contact:

Mona Doucet

Director of the Development Office

506-544-2370

What specific metrics will be used to measure the success of ‘Project Chimera’?

Key Highlights from the 2025 AGM

The Archyde Annual General Meeting (AGM), held on July 8th, 2025, was a resounding success, bringing together shareholders, board members, and key stakeholders to review the company’s performance and chart the course for future growth. This report details the key discussions, decisions, and insights shared during the meeting, offering a comprehensive overview for those who attended and those who wish to stay informed. Understanding AGM reports is crucial for transparency and corporate governance.

Financial Performance Review: 2024-2025

A detailed presentation of Archyde’s financial performance over the past fiscal year was delivered by CFO, eleanor Vance. Key takeaways included:

Revenue Growth: Archyde experienced a 15% increase in overall revenue, driven primarily by expansion into new markets and the accomplished launch of the ‘Nova’ product line. This demonstrates strong financial reporting and effective market strategies.

Profitability: Net profit margin increased to 8.2%, a meaningful advancement from 6.5% in the previous year. This was attributed to streamlined operations and effective cost management.

Shareholder Value: Earnings per share (EPS) rose to $2.75, reflecting the company’s commitment to delivering value to its shareholders. Analyzing shareholder equity is a key component of AGM review.

Dividend Declaration: The board proposed and approved a dividend of $0.50 per share,payable on August 15th,2025,to shareholders of record as of July 22nd,2025. This is a positive indicator of dividend policy and financial health.

Strategic Initiatives and Future Outlook

CEO,Marcus Bellwether,outlined the company’s strategic initiatives for the coming year,focusing on innovation,sustainability,and market expansion.

Product development: Continued investment in research and development, with a focus on AI-powered solutions and enhanced user experience. The ‘Project Chimera’ initiative, aimed at developing a next-generation platform, received significant attention.

Market Expansion: Plans to enter the Southeast Asian market in Q1 2026, leveraging strategic partnerships and localized marketing campaigns. This expansion requires careful market analysis and risk assessment.

Sustainability Initiatives: Archyde reaffirmed its commitment to environmental sustainability, announcing a new partnership with ‘GreenTech Solutions’ to reduce its carbon footprint by 20% by 2028. ESG reporting is becoming increasingly important to investors.

Digital Conversion: Accelerating the company’s digital transformation efforts, including the implementation of a new CRM system and the adoption of cloud-based technologies.This is vital for maintaining competitive advantage.

Board of Directors Updates

Shareholders re-elected all incumbent board members for another term. A notable discussion revolved around board diversity and the ongoing efforts to enhance representation. The importance of corporate governance and board composition was emphasized.

New Committee Appointments: Sarah chen was appointed as the chair of the newly formed Innovation Committee, tasked with identifying and evaluating emerging technologies.

Executive Compensation: A report on executive compensation was presented, outlining the performance-based incentives and alignment with shareholder interests.Transparency in executive pay is a key concern for many investors.

shareholder Q&A Session

A robust Q&A session followed the presentations, allowing shareholders to directly address the board and management team. Common themes included:

Competition: Questions regarding the competitive landscape and Archyde’s strategies to maintain market share.

Cybersecurity: Concerns about data security and the company’s measures to protect against cyber threats. Robust cybersecurity measures are paramount in today’s digital habitat.

Supply Chain Resilience: Inquiries about the company’s efforts to build a more resilient supply chain in light of recent global disruptions.

Long-Term Growth Strategy: Shareholders sought clarification on the company’s long-term vision and plans for lasting growth.

Voting Results & Resolutions

All resolutions presented to shareholders were approved with a significant majority. Thes included:

1. Approval of the audited financial statements for the fiscal year 2024-2025.
2. Re-election of all incumbent board members.
3. Ratification of the appointment of the independent auditor.
4. Approval of the proposed dividend payment.

Detailed voting results are available on the Archyde investor relations website. Understanding proxy voting and shareholder rights is essential for active participation.

Benefits of Attending and Reviewing the AGM Report

increased Transparency: Gain a clear understanding of the company’s performance, strategy, and governance.

informed Investment Decisions: Make more informed decisions about your investment in Archyde.

Direct Engagement: Chance to engage directly with the board and management team.

Stay Updated: Keep abreast of the latest developments and future plans for the company.

Practical Tips for AGM Participation

Review the Proxy Materials: Carefully review the proxy statement and other materials sent prior to the meeting.

Prepare questions: Prepare thoughtful questions to ask during the Q&A session.

* Vote Your shares: Exercise your